WOCKPHARMA - Technical Analysis with Chart Patterns & Indicators

Last Updated Time : 20 Dec 25, 03:55 pm

Technical Rating: 3.4

📊 Chart & Trend Analysis:

WOCKPHARMA is trading at ₹1,411, slightly above its 50 DMA (₹1,368) and 200 DMA (₹1,393), suggesting mild bullish bias. RSI at 54.2 indicates neutral momentum, neither overbought nor oversold. MACD at 1.97 shows a positive crossover, hinting at short-term bullish signals. Bollinger Bands place the price near the mid-range, reflecting consolidation. Current volume (5,53,197) is above the 1-week average (4,71,121), showing increased participation and potential accumulation.

🔎 Momentum Signals:

- Short-term momentum: Mildly bullish.

- Support levels: ₹1,380 (DMA 200), ₹1,350, ₹1,300.

- Resistance levels: ₹1,450, ₹1,500, ₹1,600.

- Optimal entry zone: ₹1,380–1,410.

- Optimal exit zone: ₹1,450–1,550.

- Current phase: Consolidation with bullish undertone.

Positive

• EPS of ₹8.68 reflects profitability despite challenges.
• Quarterly profit variation (+250%) shows strong rebound momentum.
• Stock trading above both 50 DMA and 200 DMA confirms technical strength.
• Volume above average indicates active investor interest.

Limitation

• Extremely high P/E ratio (163) compared to industry average (30.6) suggests severe overvaluation.
• ROCE (4.40%) and ROE (-0.53%) highlight weak capital efficiency.
• PEG ratio of 6.73 indicates growth does not justify valuation.
• Debt-to-equity ratio of 0.76 is relatively high, adding financial risk.

Company Negative News

• FII holding decreased by -0.19%, reflecting reduced foreign investor confidence.
• Quarterly PAT declined from ₹69 Cr. to ₹54 Cr., showing earnings weakness.

Company Positive News

• Quarterly profit variation (+250%) highlights strong turnaround momentum.
• Stable trading above key moving averages supports technical resilience.

Industry

• Industry P/E at 30.6 is far lower than WOCKPHARMA’s, suggesting peers trade at more attractive valuations.
• Pharma sector outlook remains stable with long-term demand drivers.

Conclusion

⚡ WOCKPHARMA is consolidating with mild bullish signals supported by MACD and volume. Entry near ₹1,380–1,410 offers favorable risk-reward, while exits around ₹1,450–1,550 are optimal. Strong profit rebound and technical resilience balance out valuation concerns and weak efficiency metrics. Short-term trend is sideways-to-up, with potential breakout if momentum sustains.